Langberg CW, Horndalsveen H, Helland Å, Haakensen VD (2023) Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC Front Oncol, 13, 1217424 DOI 10.3389/fonc.2023.1217424, PubMed 37476372 Gulati G, Tjessem KH, Horndalsveen H, Halvorsen S, Haakensen VD (2022) [Checkpoint inhibitor-induced myocarditis] Tidsskr Nor Laegeforen, 142 (18) DOI 10.4045/tidsskr.21.0817, PubMed 36511752 Horndalsveen H, Alver TN, Dalsgaard AM, Rogg LV, Helbekkmo N, Grønberg BH, Halvorsen TO, Ramberg C, Haakensen VD, Öjlert ÅK, Bjaanaes MM, Helland Å (2022) Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial Mol Oncol, 17 (3), 487-498 DOI 10.1002/1878-0261.13330, PubMed 36330681
